D. Scott LaMontagne, PhD, MPH, FRSPH, CS, is an epidemiologist and director of HPV vaccine programs at PATH, providing scientific and technical leadership to a range of HPV vaccine projects including an RCT of alternative 2-dose HPV vaccination schedules, operational research on single-dose HPV vaccination schedules, and micro-costing and cost-effectiveness analyses of HPV vaccine delivery. He manages PATH's HPV technical assistance team which has directly supported more than two dozen LMICs in planning, implementing, and evaluating HPV vaccination programs. He has authored and co-authored numerous papers on the clinical and operational aspects of HPV vaccine delivery in developing countries and is a recognized international expert in HPV vaccine delivery and evaluation in low-resource settings. Dr. LaMontagne has over 20 years of experience in infectious disease surveillance, operations and implementation research, public health program implementation, monitoring and evaluation, and project management for government and nongovernmental agencies in developed and developing countries.